Emergence of VIM-1-producing Salmonella enterica serovar Typhimurium in a paediatric patient
The bla VIM gene encodes a metallo-blactamase enzyme with activity against most b-lactams, including carbapenems (Queenan & Bush, 2007) . The gene is most often found as an integron-borne gene cassette with high mobility among plasmids, chromosomes and other integrons. It was described initially in Pseudomonas aeruginosa (Lauretti et al., 1999) but has disseminated to the Enterobacteriaceae (Queenan & Bush, 2007) .
In April 2014, a carbapenem-resistant Salmonella enterica isolate was recovered from a stool culture. The patient was a 5-year-old girl who had had an incomplete liver tumour resection 1 year before. She underwent another intervention because of complications derived from the first surgery, and during the early post-surgical period developed cardiorespiratory arrest, which resulted in hypoxic ischaemic encephalopathy, with her needing gastrostomy feeding since then. In April 2014, she was sent to our hospital for a new surgical intervention for the liver tumour. After surgery, she received amoxicillin/ clavulanic acid for 5 days. On day 10, she developed diarrhoea and low gastrointestinal bleeding with fever and leukocytosis. She received hydroelectrolyte replacement and recovered without antibiotic treatment. S. enterica subsp. enterica serovar Typhimurium was isolated from a stool culture. Contact and enteric precautions were established and no more infection was detected.
Antimicrobial susceptibility testing was performed by broth microdilution method (Microscan; Siemens) and the results interpreted according to EUCAST breakpoints (EUCAST, 2015) . The isolate was resistant to all b-lactams tested except aztreonam (Table 1) . Carbapenem resistance was confirmed by Etest (bioMérieux). A modified Hodge test and a double-disk synergy test with imipenem and EDTA were positive, suggesting production of a metallo-b-lactamase (Lee et al., 2003) . In addition to b-lactams, the isolate was resistant to gentamicin and tobramycin, minocycline and trimethoprim-sulfamethoxazole, and remained susceptible to amikacin, fluoroquinolones, colistin, fosfomycin and nitrofurantoin (Table 1) .
PCR testing for carbapenemases and extended-spectrum b-lactamases showed the presence of a bla VIM gene, which was identified by sequencing as VIM-1. A VIM-1 carbapenemase gene had been found before in our hospital associated with a class 1 integron (Cendejas et al., 2010) , so an integron-specific PCR was done and a 4 kb amplicon was obtained. Sequencing showed the PCR product to be 100 % identical to the In113 integron (GenBank accession no. AY970968). The integron contains, in 59 to 39 order, the gene cassettes bla VIM-1 -aacA4-dfr II-aadA1-catB, which confer resistance to b-lactams, aminoglycosides, cotrimoxazol and chloramphenicol.
The genome of the isolate was sequenced using a Roche 454 GS Junior System and assembled with Newbler 3.0. The sequence showed that the isolate belonged to ST34 (Larsen et al., 2012) , an expanding multiresistant clone (Sun et al., 2014; Wong et al., 2013) , had a 4 : i : 1,2 predicted serotype (Zhang et al., 2015) , and contained several metal resistance genes and genes for enterobactin and aerobactin production. A second integron was detected, as well as additional antibiotic resistance genes: bla TEM1-A , aac(3)-IIa, aac(6')Ib-cr, aadA2, catA, sul1, sul3, dfrB1 and tet(B) (Zankari et al., 2012) . The strain harboured three plasmids belonging to incompatibility groups IncI, IncFIB and IncL/M (Carattoli et al., 2014) . The presence of several repetitive sequences in these plasmids (mobile elements and integron attC recombination sites) precluded assembly of the integrons into larger contigs. Conjugation experiments using Escherichia coli BM21 as the recipient strain, followed by PCR analysis of the transconjugants, showed that the bla VIM-1 gene was co-transferred with the IncL/M plasmid. The sequence of the IncL/M contig (56.4 kb) was very similar (99 % sequence identity) to the OXA-48-producing Klebsiella pneumoniae plasmid pKPOXA-48N1 (Berger et al., 2013) and to closely related plasmids described previously in this and another hospital in Madrid (Brañas et al., 2015; Villa et al., 2014; Wesselink et al., 2012) , although it lacked the bla OXA-48 -containing region.
VIM metallo-b-lactamase has been found in our hospital in several K. pneumoniae and E. coli isolates obtained between 2005 and 2008 (Cendejas et al., 2010 , and since then has been found in several hospital sections with a low but slowly increasing prevalence, paralleling the steady increase of VIM producers in Spain (Oteo et al., 2013) . This, together with the fact that no other cases were detected, suggests that the carbapenem-resistant S. enterica isolate might have acquired the bla VIM-1 gene from another enterobacterial species in this patient or from a close contact. VIM-2-producing Salmonella have been described in an epidemiological survey in humans (Le Hello et al., 2013), but this is, to the best of our knowledge, the first case of nosocomial infection by a VIM-1 carbapenemaseproducing Salmonella enterica.
Production of VIM-2 carbapenemase has been reported to decrease fitness in S. enterica Typhimurium (Cordeiro et al., 2014), and this may limit the spread of these carbapenemase genes in this species. This suggests that dissemination of VIMproducing Salmonella is unlikely, although sporadic cases may occur in the context of the current expansion of carbapenemaseproducing Enterobacteriaceae (Cantó n et al., 2012). The GenBank/EMBL/DDBJ accession number for the sequence of Salmonella enterica serovar Typhimurium strain StVIM determined in this study is LIDY00000000. Carattoli, A., Zankari, E., García-Ferná ndez, A., Voldby Larsen, M., Lund, O., Villa, L., Møller Aarestrup, F. & Hasman, H. (2014) . In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother 58, 3895-3903.
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